-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Wales boss Tandy expects Rees-Zammit to make bench impact against the Pumas
-
James Watson, Nobel prize-winning DNA pioneer, dead at 97
-
Medical all-clear after anti-Trump package opened at US base
-
Sabalenka beats Anisimova in pulsating WTA Finals semi
-
Iran unveils monument to ancient victory in show of post-war defiance
-
MLS Revolution name Mitrovic as hew head coach
-
Brazil court reaches majority to reject Bolsonaro appeal against jail term
-
Norris grabs pole for Brazilian Grand Prix sprint race
-
More than 1,200 flights cut across US in govt paralysis
-
NFL Cowboys mourn death of defensive end Kneeland at 24
-
At COP30, nations target the jet set with luxury flight tax
-
Trump hosts Hungary's Orban, eyes Russian oil sanctions carve-out
-
All Blacks 'on edge' to preserve unbeaten Scotland run, says Savea
-
Alpine say Colapinto contract about talent not money
-
Return of centuries-old manuscripts key to France-Mexico talks
-
Byrne adamant Fiji no longer overawed by England
-
Ex-footballer Barton guilty over 'grossly offensive' X posts
-
Key nominees for the 2026 Grammy Awards
-
Brazil court mulls Bolsonaro appeal against jail term
-
Rybakina sinks Pegula to reach WTA Finals title match
-
Earth 'can no longer sustain' intensive fossil fuel use, Lula tells COP30
-
Kendrick Lamar leads Grammy noms with nine
-
Ex-British soldier fights extradition over Kenyan woman's murder
-
Kolisi to hit Test century with his children watching
-
Alex Marquez fastest in practice ahead of Portuguese MotoGP
-
Will 'war profiteer' Norway come to Ukraine's financial rescue?
-
Tech selloff drags stocks down on AI bubble fears
-
Blasts at Indonesia school mosque injure more than 50
-
Contepomi says lead-in to Wales match a 'challenge' for Argentina
-
Greece woos US energy deals, as eco groups cry foul
-
Frank says Spurs supporting Udogie through 'terrible situation'
-
MSF warns of missing civilians in Sudan's El-Fasher
-
Norris on top as McLaren dominate opening Sao Paulo practice
-
UN warns 'intensified hostilities' ahead in Sudan despite RSF backing truce plan
-
Seven hospitalized after suspicious package opened at US base
-
Guardiola says 'numbers are insane' as he reaches 1,000 games in charge
-
Brazil welcomes China lift of ban on poultry imports
-
Scotland captain Tuipulotu bids for landmark win over All Blacks
-
Woman convicted in UK of harassing Maddie McCann's parents
-
Tanzania charges more than 100 with treason over election protests
-
Nexperia chip exports resuming: German auto supplier
-
Genge warns England to beware 'nasty' Fiji at Twickenham
-
Stocks fall on renewed AI bubble fears
-
UK grandmother on Indonesia death row arrives back in London
-
Spanish star Rosalia reaches for divine in new album
-
Portugal's Mendes out injured as Neves returns for World Cup qualifiers
-
Afghan-Pakistan peace talks push ahead after border clashes
-
Fleetwood in tie for lead at halfway stage in Abu Dhabi
-
Brazil court starts hearing Bolsonaro appeal
French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
X.Karnes--AMWN